Streamlining success: How integrated evidence planning transforms asset development

Published on: Feb 27, 2025

Download the playbook

Integrated evidence planning is crucial for aligning evidence generation with stakeholder needs.  Explore our robust and actionable insights, with a multistakeholder perspective on optimizing product development and reducing time to market, through strategic evidence generation.

Inside, you'll learn:

  • How Integrated Evidence Plans (IEPs) create a path to market approval, access, and uptake
  • Practices for IEP implementation and delivery, streamlining and accelerating development
  • Strategies to maximize IEP value, including real-world evidence use
  • Industry insights on current IEP practices and challenges
     

IEP Chart 1.jpg

Download the playbook

Start a conversation

Return to Insights Center

Related Insights

Playbook

Are you using real-world evidence?

Feb 1, 2023

Blog

Breaking through complex regulations and science speak – thinking “patients first” in lay language summary development

Jun 22, 2021

Blog

Accelerating Delivery and Patient Access to Rare Disease Treatments – Highlights from World Orphan Drug Congress

May 2, 2024

Article

New FDA Guidance Addresses the Need for Data-Generation Strategies Across the Drug Development Lifecycle

May 10, 2022

Blog

Maintaining Data Integrity for Quality and Compliance – Essential Despite Pandemic Disruptions

May 16, 2022

Video

Creating EU-CTR compliant and patient-friendly lay language summaries (LLS)

Jan 26, 2022

Report

New Medicines, Novel Insights: Accelerating development of cell and gene therapies

May 22, 2023

Webinar

Assessing appropriate use of ECAs in clinical trials

May 28, 2023

Article

Near-term strategies for biotech drug developers facing shifting healthcare dynamics

Feb 14, 2024

Report

New Medicines, Novel Insights: Advancing rare disease drug development

May 22, 2023

Whitepaper

The Chinese Pharmaceutical Market: Size, R&D, Regulations, Market Access and Innovations

Mar 9, 2023

Video

The science and practice of ethnobridging

May 17, 2023

Related Insights

Playbook

Are you using real-world evidence?

Feb 1, 2023

Blog

Breaking through complex regulations and science speak – thinking “patients first” in lay language summary development

Jun 22, 2021

Blog

Accelerating Delivery and Patient Access to Rare Disease Treatments – Highlights from World Orphan Drug Congress

May 2, 2024

Article

New FDA Guidance Addresses the Need for Data-Generation Strategies Across the Drug Development Lifecycle

May 10, 2022

Blog

Maintaining Data Integrity for Quality and Compliance – Essential Despite Pandemic Disruptions

May 16, 2022

Video

Creating EU-CTR compliant and patient-friendly lay language summaries (LLS)

Jan 26, 2022

Show more